Global Fostamatinib Tablets Market Growth 2026-2032

September 2026 | 92 pages | ID: G6285F2F5210EN
LP Information

Abstracts

The global Fostamatinib Tablets market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

United States market for Fostamatinib Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Fostamatinib Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Fostamatinib Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Fostamatinib Tablets players cover Rigel Pharmaceuticals, Kissei Pharmaceutical, Grifols, JW Pharmaceutical Corporation, Medison Pharma Canada, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LP Information, Inc. (LPI) ' newest research report, the “Fostamatinib Tablets Industry Forecast” looks at past sales and reviews total world Fostamatinib Tablets sales in 2025, providing a comprehensive analysis by region and market sector of projected Fostamatinib Tablets sales for 2026 through 2032. With Fostamatinib Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Fostamatinib Tablets industry.

This Insight Report provides a comprehensive analysis of the global Fostamatinib Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Fostamatinib Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Fostamatinib Tablets market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Fostamatinib Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Fostamatinib Tablets.

This report presents a comprehensive overview, market shares, and growth opportunities of Fostamatinib Tablets market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• 100 mg
• 150 mg

Segmentation by Application:

• Chronic Immune Thrombocytopenia (ITP)
• Waldenstr?m's Macroglobulinemia
• Autoimmune Haemolytic Anaemia
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Rigel Pharmaceuticals
• Kissei Pharmaceutical
• Grifols
• JW Pharmaceutical Corporation
• Medison Pharma Canada
• AstraZeneca

Key Questions Addressed in this Report

• What is the 10-year outlook for the global Fostamatinib Tablets market?
• What factors are driving Fostamatinib Tablets market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do Fostamatinib Tablets market opportunities vary by end market size?
• How does Fostamatinib Tablets break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

  1.1 Market Introduction
  1.2 Years Considered
  1.3 Research Objectives
  1.4 Market Research Methodology
  1.5 Research Process and Data Source
  1.6 Economic Indicators
  1.7 Currency Considered
  1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

  2.1 World Market Overview
  2.1.1 Global Fostamatinib Tablets Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Fostamatinib Tablets by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Fostamatinib Tablets by Country/Region, 2021, 2025 & 2032
  2.2 Fostamatinib Tablets Segment by Type
  2.2.1 100 mg
  2.2.2 150 mg
  2.2.3 Fostamatinib Tablets Sales by Type
  2.2.3.1 Global Fostamatinib Tablets Sales Market Share by Type (2021-2026)
  2.2.3.2 Global Fostamatinib Tablets Revenue and Market Share by Type (2021-2026)
  2.2.3.3 Global Fostamatinib Tablets Sale Price by Type (2021-2026)
  2.3 Fostamatinib Tablets Segment by Application
  2.3.1 Chronic Immune Thrombocytopenia (ITP)
  2.3.2 Waldenstr?m's Macroglobulinemia
  2.3.3 Autoimmune Haemolytic Anaemia
  2.3.4 Other
  2.3.5 Fostamatinib Tablets Sales by Application
  2.3.5.1 Global Fostamatinib Tablets Sale Market Share by Application (2021-2026)
  2.3.5.2 Global Fostamatinib Tablets Revenue and Market Share by Application (2021-2026)
  2.3.5.3 Global Fostamatinib Tablets Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

  3.1 Global Fostamatinib Tablets Breakdown Data by Company
  3.1.1 Global Fostamatinib Tablets Annual Sales by Company (2021-2026)
  3.1.2 Global Fostamatinib Tablets Sales Market Share by Company (2021-2026)
  3.2 Global Fostamatinib Tablets Annual Revenue by Company (2021-2026)
  3.2.1 Global Fostamatinib Tablets Revenue by Company (2021-2026)
  3.2.2 Global Fostamatinib Tablets Revenue Market Share by Company (2021-2026)
  3.3 Global Fostamatinib Tablets Sale Price by Company
  3.4 Key Manufacturers Fostamatinib Tablets Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Fostamatinib Tablets Product Location Distribution
  3.4.2 Players Fostamatinib Tablets Products Offered
  3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
  3.6 New Products and Potential Entrants
  3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR FOSTAMATINIB TABLETS BY GEOGRAPHIC REGION

  4.1 World Historic Fostamatinib Tablets Market Size by Geographic Region (2021-2026)
  4.1.1 Global Fostamatinib Tablets Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Fostamatinib Tablets Annual Revenue by Geographic Region (2021-2026)
  4.2 World Historic Fostamatinib Tablets Market Size by Country/Region (2021-2026)
  4.2.1 Global Fostamatinib Tablets Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Fostamatinib Tablets Annual Revenue by Country/Region (2021-2026)
  4.3 Americas Fostamatinib Tablets Sales Growth
  4.4 APAC Fostamatinib Tablets Sales Growth
  4.5 Europe Fostamatinib Tablets Sales Growth
  4.6 Middle East & Africa Fostamatinib Tablets Sales Growth

5 AMERICAS

  5.1 Americas Fostamatinib Tablets Sales by Country
  5.1.1 Americas Fostamatinib Tablets Sales by Country (2021-2026)
  5.1.2 Americas Fostamatinib Tablets Revenue by Country (2021-2026)
  5.2 Americas Fostamatinib Tablets Sales by Type (2021-2026)
  5.3 Americas Fostamatinib Tablets Sales by Application (2021-2026)
  5.4 United States
  5.5 Canada
  5.6 Mexico
  5.7 Brazil

6 APAC

  6.1 APAC Fostamatinib Tablets Sales by Region
  6.1.1 APAC Fostamatinib Tablets Sales by Region (2021-2026)
  6.1.2 APAC Fostamatinib Tablets Revenue by Region (2021-2026)
  6.2 APAC Fostamatinib Tablets Sales by Type (2021-2026)
  6.3 APAC Fostamatinib Tablets Sales by Application (2021-2026)
  6.4 China
  6.5 Japan
  6.6 South Korea
  6.7 Southeast Asia
  6.8 India
  6.9 Australia
  6.10 China Taiwan

7 EUROPE

  7.1 Europe Fostamatinib Tablets by Country
  7.1.1 Europe Fostamatinib Tablets Sales by Country (2021-2026)
  7.1.2 Europe Fostamatinib Tablets Revenue by Country (2021-2026)
  7.2 Europe Fostamatinib Tablets Sales by Type (2021-2026)
  7.3 Europe Fostamatinib Tablets Sales by Application (2021-2026)
  7.4 Germany
  7.5 France
  7.6 UK
  7.7 Italy
  7.8 Russia

8 MIDDLE EAST & AFRICA

  8.1 Middle East & Africa Fostamatinib Tablets by Country
  8.1.1 Middle East & Africa Fostamatinib Tablets Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Fostamatinib Tablets Revenue by Country (2021-2026)
  8.2 Middle East & Africa Fostamatinib Tablets Sales by Type (2021-2026)
  8.3 Middle East & Africa Fostamatinib Tablets Sales by Application (2021-2026)
  8.4 Egypt
  8.5 South Africa
  8.6 Israel
  8.7 Turkey
  8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

  9.1 Market Drivers & Growth Opportunities
  9.2 Market Challenges & Risks
  9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

  10.1 Raw Material and Suppliers
  10.2 Manufacturing Cost Structure Analysis of Fostamatinib Tablets
  10.3 Manufacturing Process Analysis of Fostamatinib Tablets
  10.4 Industry Chain Structure of Fostamatinib Tablets

11 MARKETING, DISTRIBUTORS AND CUSTOMER

  11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
  11.2 Fostamatinib Tablets Distributors
  11.3 Fostamatinib Tablets Customer

12 WORLD FORECAST REVIEW FOR FOSTAMATINIB TABLETS BY GEOGRAPHIC REGION

  12.1 Global Fostamatinib Tablets Market Size Forecast by Region
  12.1.1 Global Fostamatinib Tablets Forecast by Region (2027-2032)
  12.1.2 Global Fostamatinib Tablets Annual Revenue Forecast by Region (2027-2032)
  12.2 Americas Forecast by Country (2027-2032)
  12.3 APAC Forecast by Region (2027-2032)
  12.4 Europe Forecast by Country (2027-2032)
  12.5 Middle East & Africa Forecast by Country (2027-2032)
  12.6 Global Fostamatinib Tablets Forecast by Type (2027-2032)
  12.7 Global Fostamatinib Tablets Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

  13.1 Rigel Pharmaceuticals
  13.1.1 Rigel Pharmaceuticals Company Information
  13.1.2 Rigel Pharmaceuticals Fostamatinib Tablets Product Portfolios and Specifications
  13.1.3 Rigel Pharmaceuticals Fostamatinib Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Rigel Pharmaceuticals Main Business Overview
  13.1.5 Rigel Pharmaceuticals Latest Developments
  13.2 Kissei Pharmaceutical
  13.2.1 Kissei Pharmaceutical Company Information
  13.2.2 Kissei Pharmaceutical Fostamatinib Tablets Product Portfolios and Specifications
  13.2.3 Kissei Pharmaceutical Fostamatinib Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 Kissei Pharmaceutical Main Business Overview
  13.2.5 Kissei Pharmaceutical Latest Developments
  13.3 Grifols
  13.3.1 Grifols Company Information
  13.3.2 Grifols Fostamatinib Tablets Product Portfolios and Specifications
  13.3.3 Grifols Fostamatinib Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Grifols Main Business Overview
  13.3.5 Grifols Latest Developments
  13.4 JW Pharmaceutical Corporation
  13.4.1 JW Pharmaceutical Corporation Company Information
  13.4.2 JW Pharmaceutical Corporation Fostamatinib Tablets Product Portfolios and Specifications
  13.4.3 JW Pharmaceutical Corporation Fostamatinib Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 JW Pharmaceutical Corporation Main Business Overview
  13.4.5 JW Pharmaceutical Corporation Latest Developments
  13.5 Medison Pharma Canada
  13.5.1 Medison Pharma Canada Company Information
  13.5.2 Medison Pharma Canada Fostamatinib Tablets Product Portfolios and Specifications
  13.5.3 Medison Pharma Canada Fostamatinib Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 Medison Pharma Canada Main Business Overview
  13.5.5 Medison Pharma Canada Latest Developments
  13.6 AstraZeneca
  13.6.1 AstraZeneca Company Information
  13.6.2 AstraZeneca Fostamatinib Tablets Product Portfolios and Specifications
  13.6.3 AstraZeneca Fostamatinib Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 AstraZeneca Main Business Overview
  13.6.5 AstraZeneca Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Fostamatinib Tablets Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Fostamatinib Tablets Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 100 mg
Table 4. Major Players of 150 mg
Table 5. Global Fostamatinib Tablets Sales by Type (2021-2026) & (K Units)
Table 6. Global Fostamatinib Tablets Sales Market Share by Type (2021-2026)
Table 7. Global Fostamatinib Tablets Revenue by Type (2021-2026) & ($ million)
Table 8. Global Fostamatinib Tablets Revenue Market Share by Type (2021-2026)
Table 9. Global Fostamatinib Tablets Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Fostamatinib Tablets Sale by Application (2021-2026) & (K Units)
Table 11. Global Fostamatinib Tablets Sale Market Share by Application (2021-2026)
Table 12. Global Fostamatinib Tablets Revenue by Application (2021-2026) & ($ million)
Table 13. Global Fostamatinib Tablets Revenue Market Share by Application (2021-2026)
Table 14. Global Fostamatinib Tablets Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Fostamatinib Tablets Sales by Company (2021-2026) & (K Units)
Table 16. Global Fostamatinib Tablets Sales Market Share by Company (2021-2026)
Table 17. Global Fostamatinib Tablets Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Fostamatinib Tablets Revenue Market Share by Company (2021-2026)
Table 19. Global Fostamatinib Tablets Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Fostamatinib Tablets Producing Area Distribution and Sales Area
Table 21. Players Fostamatinib Tablets Products Offered
Table 22. Fostamatinib Tablets Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Fostamatinib Tablets Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Fostamatinib Tablets Sales Market Share Geographic Region (2021-2026)
Table 27. Global Fostamatinib Tablets Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Fostamatinib Tablets Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Fostamatinib Tablets Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Fostamatinib Tablets Sales Market Share by Country/Region (2021-2026)
Table 31. Global Fostamatinib Tablets Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Fostamatinib Tablets Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Fostamatinib Tablets Sales by Country (2021-2026) & (K Units)
Table 34. Americas Fostamatinib Tablets Sales Market Share by Country (2021-2026)
Table 35. Americas Fostamatinib Tablets Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Fostamatinib Tablets Sales by Type (2021-2026) & (K Units)
Table 37. Americas Fostamatinib Tablets Sales by Application (2021-2026) & (K Units)
Table 38. APAC Fostamatinib Tablets Sales by Region (2021-2026) & (K Units)
Table 39. APAC Fostamatinib Tablets Sales Market Share by Region (2021-2026)
Table 40. APAC Fostamatinib Tablets Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Fostamatinib Tablets Sales by Type (2021-2026) & (K Units)
Table 42. APAC Fostamatinib Tablets Sales by Application (2021-2026) & (K Units)
Table 43. Europe Fostamatinib Tablets Sales by Country (2021-2026) & (K Units)
Table 44. Europe Fostamatinib Tablets Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Fostamatinib Tablets Sales by Type (2021-2026) & (K Units)
Table 46. Europe Fostamatinib Tablets Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Fostamatinib Tablets Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Fostamatinib Tablets Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Fostamatinib Tablets Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Fostamatinib Tablets Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Fostamatinib Tablets
Table 52. Key Market Challenges & Risks of Fostamatinib Tablets
Table 53. Key Industry Trends of Fostamatinib Tablets
Table 54. Fostamatinib Tablets Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Fostamatinib Tablets Distributors List
Table 57. Fostamatinib Tablets Customer List
Table 58. Global Fostamatinib Tablets Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Fostamatinib Tablets Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Fostamatinib Tablets Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Fostamatinib Tablets Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Fostamatinib Tablets Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Fostamatinib Tablets Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Fostamatinib Tablets Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Fostamatinib Tablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Fostamatinib Tablets Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Fostamatinib Tablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Fostamatinib Tablets Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Fostamatinib Tablets Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Fostamatinib Tablets Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Fostamatinib Tablets Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Rigel Pharmaceuticals Basic Information, Fostamatinib Tablets Manufacturing Base, Sales Area and Its Competitors
Table 73. Rigel Pharmaceuticals Fostamatinib Tablets Product Portfolios and Specifications
Table 74. Rigel Pharmaceuticals Fostamatinib Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Rigel Pharmaceuticals Main Business
Table 76. Rigel Pharmaceuticals Latest Developments
Table 77. Kissei Pharmaceutical Basic Information, Fostamatinib Tablets Manufacturing Base, Sales Area and Its Competitors
Table 78. Kissei Pharmaceutical Fostamatinib Tablets Product Portfolios and Specifications
Table 79. Kissei Pharmaceutical Fostamatinib Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Kissei Pharmaceutical Main Business
Table 81. Kissei Pharmaceutical Latest Developments
Table 82. Grifols Basic Information, Fostamatinib Tablets Manufacturing Base, Sales Area and Its Competitors
Table 83. Grifols Fostamatinib Tablets Product Portfolios and Specifications
Table 84. Grifols Fostamatinib Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Grifols Main Business
Table 86. Grifols Latest Developments
Table 87. JW Pharmaceutical Corporation Basic Information, Fostamatinib Tablets Manufacturing Base, Sales Area and Its Competitors
Table 88. JW Pharmaceutical Corporation Fostamatinib Tablets Product Portfolios and Specifications
Table 89. JW Pharmaceutical Corporation Fostamatinib Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. JW Pharmaceutical Corporation Main Business
Table 91. JW Pharmaceutical Corporation Latest Developments
Table 92. Medison Pharma Canada Basic Information, Fostamatinib Tablets Manufacturing Base, Sales Area and Its Competitors
Table 93. Medison Pharma Canada Fostamatinib Tablets Product Portfolios and Specifications
Table 94. Medison Pharma Canada Fostamatinib Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Medison Pharma Canada Main Business
Table 96. Medison Pharma Canada Latest Developments
Table 97. AstraZeneca Basic Information, Fostamatinib Tablets Manufacturing Base, Sales Area and Its Competitors
Table 98. AstraZeneca Fostamatinib Tablets Product Portfolios and Specifications
Table 99. AstraZeneca Fostamatinib Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. AstraZeneca Main Business
Table 101. AstraZeneca Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Fostamatinib Tablets
Figure 2. Fostamatinib Tablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Fostamatinib Tablets Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Fostamatinib Tablets Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Fostamatinib Tablets Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Fostamatinib Tablets Sales Market Share by Country/Region (2025)
Figure 10. Fostamatinib Tablets Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 100 mg
Figure 12. Product Picture of 150 mg
Figure 13. Global Fostamatinib Tablets Sales Market Share by Type in 2026
Figure 14. Global Fostamatinib Tablets Revenue Market Share by Type (2021-2026)
Figure 15. Fostamatinib Tablets Consumed in Chronic Immune Thrombocytopenia (ITP)
Figure 16. Global Fostamatinib Tablets Market: Chronic Immune Thrombocytopenia (ITP) (2021-2026) & (K Units)
Figure 17. Fostamatinib Tablets Consumed in Waldenstr?m's Macroglobulinemia
Figure 18. Global Fostamatinib Tablets Market: Waldenstr?m's Macroglobulinemia (2021-2026) & (K Units)
Figure 19. Fostamatinib Tablets Consumed in Autoimmune Haemolytic Anaemia
Figure 20. Global Fostamatinib Tablets Market: Autoimmune Haemolytic Anaemia (2021-2026) & (K Units)
Figure 21. Fostamatinib Tablets Consumed in Other
Figure 22. Global Fostamatinib Tablets Market: Other (2021-2026) & (K Units)
Figure 23. Global Fostamatinib Tablets Sale Market Share by Application (2025)
Figure 24. Global Fostamatinib Tablets Revenue Market Share by Application in 2026
Figure 25. Fostamatinib Tablets Sales by Company in 2026 (K Units)
Figure 26. Global Fostamatinib Tablets Sales Market Share by Company in 2026
Figure 27. Fostamatinib Tablets Revenue by Company in 2026 ($ millions)
Figure 28. Global Fostamatinib Tablets Revenue Market Share by Company in 2026
Figure 29. Global Fostamatinib Tablets Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Fostamatinib Tablets Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Fostamatinib Tablets Sales 2021-2026 (K Units)
Figure 32. Americas Fostamatinib Tablets Revenue 2021-2026 ($ millions)
Figure 33. APAC Fostamatinib Tablets Sales 2021-2026 (K Units)
Figure 34. APAC Fostamatinib Tablets Revenue 2021-2026 ($ millions)
Figure 35. Europe Fostamatinib Tablets Sales 2021-2026 (K Units)
Figure 36. Europe Fostamatinib Tablets Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Fostamatinib Tablets Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa Fostamatinib Tablets Revenue 2021-2026 ($ millions)
Figure 39. Americas Fostamatinib Tablets Sales Market Share by Country in 2026
Figure 40. Americas Fostamatinib Tablets Revenue Market Share by Country (2021-2026)
Figure 41. Americas Fostamatinib Tablets Sales Market Share by Type (2021-2026)
Figure 42. Americas Fostamatinib Tablets Sales Market Share by Application (2021-2026)
Figure 43. United States Fostamatinib Tablets Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Fostamatinib Tablets Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Fostamatinib Tablets Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Fostamatinib Tablets Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Fostamatinib Tablets Sales Market Share by Region in 2026
Figure 48. APAC Fostamatinib Tablets Revenue Market Share by Region (2021-2026)
Figure 49. APAC Fostamatinib Tablets Sales Market Share by Type (2021-2026)
Figure 50. APAC Fostamatinib Tablets Sales Market Share by Application (2021-2026)
Figure 51. China Fostamatinib Tablets Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Fostamatinib Tablets Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Fostamatinib Tablets Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Fostamatinib Tablets Revenue Growth 2021-2026 ($ millions)
Figure 55. India Fostamatinib Tablets Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Fostamatinib Tablets Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Fostamatinib Tablets Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Fostamatinib Tablets Sales Market Share by Country in 2026
Figure 59. Europe Fostamatinib Tablets Revenue Market Share by Country (2021-2026)
Figure 60. Europe Fostamatinib Tablets Sales Market Share by Type (2021-2026)
Figure 61. Europe Fostamatinib Tablets Sales Market Share by Application (2021-2026)
Figure 62. Germany Fostamatinib Tablets Revenue Growth 2021-2026 ($ millions)
Figure 63. France Fostamatinib Tablets Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Fostamatinib Tablets Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Fostamatinib Tablets Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Fostamatinib Tablets Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Fostamatinib Tablets Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Fostamatinib Tablets Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Fostamatinib Tablets Sales Market Share by Application (2021-2026)
Figure 70. Egypt Fostamatinib Tablets Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Fostamatinib Tablets Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Fostamatinib Tablets Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Fostamatinib Tablets Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Fostamatinib Tablets Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Fostamatinib Tablets in 2026
Figure 76. Manufacturing Process Analysis of Fostamatinib Tablets
Figure 77. Industry Chain Structure of Fostamatinib Tablets
Figure 78. Channels of Distribution
Figure 79. Global Fostamatinib Tablets Sales Market Forecast by Region (2027-2032)
Figure 80. Global Fostamatinib Tablets Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Fostamatinib Tablets Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Fostamatinib Tablets Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Fostamatinib Tablets Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Fostamatinib Tablets Revenue Market Share Forecast by Application (2027-2032)